Home / Drug shortages / Lincomycin Hydrochloride Injection

Lincomycin Hydrochloride Injection — FDA Drug Shortage

To Be Discontinued — XGen Pharmaceuticals DJB, Inc.

The FDA lists a drug shortage record for Lincomycin Hydrochloride Injection (injection) from XGen Pharmaceuticals DJB, Inc. with status To Be Discontinued. The shortage was first posted on 03/26/2026.

Shortage Details

Status
To Be Discontinued
Company
XGen Pharmaceuticals DJB, Inc.
Package NDC
39822-0355-6
Dosage Form
Injection
Presentation
Lincomycin Hydrochloride, Injection, 3 grams/10 mL vial x 10 count (NDC 39822-0355-6)
Initial Posting
03/26/2026
Revised Date

FDA data resources